FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2785248466> ?p ?o ?g. }

• W2785248466 endingPage "433" @default.
• W2785248466 startingPage "423" @default.
• W2785248466 abstract "Objective The Epi-IBD cohort is a prospective population-based inception cohort of unselected patients with inflammatory bowel disease from 29 European centres covering a background population of almost 10 million people. The aim of this study was to assess the 5-year outcome and disease course of patients with Crohn’s disease (CD). Design Patients were followed up prospectively from the time of diagnosis, including collection of their clinical data, demographics, disease activity, medical therapy, surgery, cancers and deaths. Associations between outcomes and multiple covariates were analysed by Cox regression analysis. Results In total, 488 patients were included in the study. During follow-up, 107 (22%) patients received surgery, while 176 (36%) patients were hospitalised because of CD. A total of 49 (14%) patients diagnosed with non-stricturing, non-penetrating disease progressed to either stricturing and/or penetrating disease. These rates did not differ between patients from Western and Eastern Europe. However, significant geographic differences were noted regarding treatment: more patients in Western Europe received biological therapy (33%) and immunomodulators (66%) than did those in Eastern Europe (14% and 54%, respectively, P<0.01), while more Eastern European patients received 5-aminosalicylates (90% vs 56%, P<0.05). Treatment with immunomodulators reduced the risk of surgery (HR: 0.4, 95% CI 0.2 to 0.6) and hospitalisation (HR: 0.3, 95% CI 0.2 to 0.5). Conclusion Despite patients being treated early and frequently with immunomodulators and biological therapy in Western Europe, 5-year outcomes including surgery and phenotype progression in this cohort were comparable across Western and Eastern Europe. Differences in treatment strategies between Western and Eastern European centres did not affect the disease course. Treatment with immunomodulators reduced the risk of surgery and hospitalisation." @default.
• W2785248466 created "2018-02-02" @default.
• W2785248466 creator A5005330357 @default.
• W2785248466 creator A5007236898 @default.
• W2785248466 creator A5007848186 @default.
• W2785248466 creator A5008566468 @default.
• W2785248466 creator A5008573277 @default.
• W2785248466 creator A5008723044 @default.
• W2785248466 creator A5013167694 @default.
• W2785248466 creator A5013593261 @default.
• W2785248466 creator A5015033532 @default.
• W2785248466 creator A5015958375 @default.
• W2785248466 creator A5016591972 @default.
• W2785248466 creator A5017642140 @default.
• W2785248466 creator A5017795689 @default.
• W2785248466 creator A5018678523 @default.
• W2785248466 creator A5019960092 @default.
• W2785248466 creator A5020584664 @default.
• W2785248466 creator A5020923863 @default.
• W2785248466 creator A5021651980 @default.
• W2785248466 creator A5023115575 @default.
• W2785248466 creator A5033989831 @default.
• W2785248466 creator A5034141472 @default.
• W2785248466 creator A5035484022 @default.
• W2785248466 creator A5036036179 @default.
• W2785248466 creator A5043240020 @default.
• W2785248466 creator A5044724667 @default.
• W2785248466 creator A5046490863 @default.
• W2785248466 creator A5049491345 @default.
• W2785248466 creator A5049988663 @default.
• W2785248466 creator A5050910391 @default.
• W2785248466 creator A5052535018 @default.
• W2785248466 creator A5056136253 @default.
• W2785248466 creator A5061087463 @default.
• W2785248466 creator A5061303817 @default.
• W2785248466 creator A5061501366 @default.
• W2785248466 creator A5062609690 @default.
• W2785248466 creator A5067108118 @default.
• W2785248466 creator A5068091489 @default.
• W2785248466 creator A5068268866 @default.
• W2785248466 creator A5068621002 @default.
• W2785248466 creator A5068975639 @default.
• W2785248466 creator A5070038178 @default.
• W2785248466 creator A5074210541 @default.
• W2785248466 creator A5082499535 @default.
• W2785248466 creator A5084212600 @default.
• W2785248466 creator A5087372337 @default.
• W2785248466 creator A5089763005 @default.
• W2785248466 date "2018-01-23" @default.
• W2785248466 modified "2023-10-18" @default.
• W2785248466 title "Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study" @default.
• W2785248466 cites W1977597570 @default.
• W2785248466 cites W1980692490 @default.
• W2785248466 cites W1997402233 @default.
• W2785248466 cites W2000368489 @default.
• W2785248466 cites W2010469688 @default.
• W2785248466 cites W2024959214 @default.
• W2785248466 cites W2053517994 @default.
• W2785248466 cites W2059357675 @default.
• W2785248466 cites W2064275071 @default.
• W2785248466 cites W2066497741 @default.
• W2785248466 cites W2076057971 @default.
• W2785248466 cites W2080410907 @default.
• W2785248466 cites W2102548728 @default.
• W2785248466 cites W2102567329 @default.
• W2785248466 cites W2113143571 @default.
• W2785248466 cites W2126103084 @default.
• W2785248466 cites W2128406046 @default.
• W2785248466 cites W2138292140 @default.
• W2785248466 cites W2143731327 @default.
• W2785248466 cites W2147324797 @default.
• W2785248466 cites W2152381563 @default.
• W2785248466 cites W2154875222 @default.
• W2785248466 cites W2161015371 @default.
• W2785248466 cites W2188248802 @default.
• W2785248466 cites W2224201356 @default.
• W2785248466 cites W228639233 @default.
• W2785248466 cites W2404725277 @default.
• W2785248466 cites W2519264967 @default.
• W2785248466 cites W2523706394 @default.
• W2785248466 cites W2528277214 @default.
• W2785248466 cites W2559823888 @default.
• W2785248466 cites W2567029831 @default.
• W2785248466 cites W2763488343 @default.
• W2785248466 doi "https://doi.org/10.1136/gutjnl-2017-315568" @default.
• W2785248466 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29363534" @default.
• W2785248466 hasPublicationYear "2018" @default.
• W2785248466 type Work @default.
• W2785248466 sameAs 2785248466 @default.
• W2785248466 citedByCount "164" @default.
• W2785248466 countsByYear W27852484662018 @default.
• W2785248466 countsByYear W27852484662019 @default.
• W2785248466 countsByYear W27852484662020 @default.
• W2785248466 countsByYear W27852484662021 @default.
• W2785248466 countsByYear W27852484662022 @default.
• W2785248466 countsByYear W27852484662023 @default.
• W2785248466 crossrefType "journal-article" @default.
• W2785248466 hasAuthorship W2785248466A5005330357 @default.

• next